Determination of methotrexate and indomethacin in urine using SPE-LC-DAD after derivatization

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 2, 2011, Pages 317-324

  Michail, Karim ^a,b   Moneeb, Marwa S ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Derivatization; Indomethacin; Liquid chromatography; Methotrexate; Solid phase extraction; Urine

Indexed keywords

IBUPROFEN; INDOMETACIN; METHOTREXATE;

ANALYTIC METHOD; ARTICLE; CHROMATOGRAPHY; DERIVATIZATION; DRUG DETERMINATION; DRUG EFFECT; DRUG SELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; RHEUMATOID ARTHRITIS; SEPARATION TECHNIQUE; TUMOR MICROENVIRONMENT; URINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOLIC ACID ANTAGONISTS; HUMANS; INDOMETHACIN; LIMIT OF DETECTION; METHOTREXATE; QUALITY CONTROL; REFERENCE STANDARDS; SOLID PHASE EXTRACTION;

EID: 79952252471     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.032     Document Type: Article

References (29)

1. Balis M.F., Holcenberk J.C., Blaney S.M. General principles of chemotherapy. Principles and Practice of Pediatric Oncology 2002, 237. Lippincott, Philadelphia. P. Pizzo, D. Poplack (Eds.).
2. Weinblatt M.E. Methotrexate for chronic diseases in adults. N. Engl. J. Med. 1995, 332:330-331.
3. Wang H.M., Zhang G.Y. Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo. World J. Gastroenterol. 2005, 11:340-343.
4. Bennett A., Gaffen J.D., Melhuish P.B., Stamford I.F. Studies on the mechanism by which indomethacin increases the anticancer effect of methotrexate. Br. J. Pharmacol. 1987, 91:229-235.
5. Kobayashi S., Okada S., Hasumi T., Sato N., Fujimura S. The marked anticancer effect of combined VCR, MTX, and indomethacin against drug-resistant recurrent small cell lung carcinoma after conventional chemotherapy: report of a case. Surg. Today 1999, 29:666-669.
6. Frenia M., Long K. Methotrexate and nonsteroidal anti-inflammatory drug interactions. Ann. Pharmacother. 1992, 26:234-237.
7. Uwai Y., Saito H., Inui K. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur. J. Pharmacol. 2000, 409:31-36.
8. Nozaki Y., Kusuhara H., Kondo T., Iwaki M., Shiroyanagi Y., Nakayama H., Horita S., Nakazawa H., Okano T., Sugiyama Y. Species difference in the inhibitory effect of nonsteroidal anti-inflammatory drugs on the uptake of methotrexate by human kidney slices. J. Phamacol. Exp. Ther. 2007, 322:1162-1170.
9. Maeda A., Tsuruoka Sh., Kanai Y., Endou H., Saito K., Miyamoto E., Fujimura A. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells. Eur. J. Pharmacol. 2008, 596:166-172.
10. Shen D., Azarnoff D. Clinical pharmacokinetics of methotrexate. Clin. Pharmacokinet. 1978, 3:1-13.
11. Davies N.M., Skjodt N.M. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach. Clin. Pharmacokinet. 2000, 38:377-392.
12. Rubino F.M. Separation methods for methotrexate, its structural analogues and metabolites. J. Chromatogr. B 2001, 764:217-254.
13. Novakova L., Matysova L., Havlikova L., Solich P. Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gel. J. Pharm. Biomed. Anal. 2005, 37:899-905.
14. Stubbs R.J., Schwartz M.S., Chioua R., Entwistle L.A., Bayne W.F. Improved method for the determination of indomethacin in plasma and urine by reversed-phase high-performance liquid chromatography. J. Chromatogr. B: Biomed. Sci. Appl. 1986, 383:432-437.
15. Vree T.B., van den Biggelaar-Martea M., Verwey-van Wissen C.P. Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis: preliminary pharmacokinetics and effect of probenecid. J. Chromatogr. B: Biomed. Sci. Appl. 1993, 616(2):271-282.
16. Niopas I., Mamzoridi K. Determination of indomethacin and mefenamic acid in plasma by high-performance liquid chromatography. J. Chromatogr. B: Biomed. Sci. Appl. 1994, 656:447-450.
17. The United States Pharmacopeia 30, The National Formulary 25 2008, The United States Pharmacopeial Convention, Inc., Rockville, MD.
18. The British Pharmacopoeia 2009, Her Majesty's Stationary Office, London.
19. Prey S., Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br. J. Dermatol. 2009, 160:622-628.
20. Bressole F., Bromet-Petit M., Audran M. Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics. J. Chromatogr. B 1996, 686:3-10.
21. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology 2005.
22. Clarke's Analysis of Drugs and Poisons 2004, 1133-1135. Pharmaceutical Press, London. 3rd ed. A.C. Moffat, M.D. Osselton, B. Widdop (Eds.).
23. Miwa H. High-performance liquid chromatographic determination of mono-, poly- and hydroxycarboxylic acids in foods and beverages as their 2-nitrophenylhydrazides. J. Chromatogr. A 2000, 881:365-385.
24. Miwa H., Hiyama C., Yamamoto M. High-performance liquid chromatography of short-and long-chain fatty acids as 2-nitrophenylhydrazides. J. Chromatogr. A 1985, 321:165-174.
25. Guidance for Industry: Bioanalytical Method Validation 2001, U.S. Department of Health and Human Services, Food and Drug Administration; Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER).
26. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharmaceut. Res. 2000, 17:1551-1557.
27. Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring 1992, Applied Therapeutics Inc., Vancouver. W.R. Crom, W.E. Evans (Eds.).
28. Duggan D.E., Hogans A.F., Kwan K.C., McMahon F.G. The metabolism of indomethacin in man. J. Pharmacol. Exp. Ther. 1972, 181:563-575.
29. Jacobs S.A., Stoller R.G., Chabner B.A., Johns D.G. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J. Clin. Investig. 1976, 57:534-538.